Application of BET/CBP/p300 multi-bromodomain inhibitors as a novel therapeutic strategy for MLL-rearranged acute lymphoblastic leukemia
Application of BET/CBP/p300 multi-bromodomain inhibitors as a novel therapeutic strategy for MLL-rearranged acute lymphoblastic leukemia
复制标题
BET/CBP/p300多溴结构域抑制剂作为MLL重排急性淋巴细胞白血病的新治疗策略的应用
DOI:
--
复制
发表时间:
2020
期刊:
影响因子:
--
通讯作者:
Eishi Ashihara.
中科院分区:
文献类型:
--
作者:
Natsuki Imayoshi;Makoto Yoshioka;Shyh-Ming Yang;Koshi Akahane;Yuki Toda;Shigekuni Hosogi;Takeshi Inukai;Seiji Okada;David J. Maloney;Jeffrey W. Strovel;Eishi Ashihara.